International investors in KMDA should review their eligibility for reduced withholding taxes and submit required documentation by May 9, 2026 to maximize after-tax dividend income. This administrative update does not signal any change in dividend policy or financial performance.
KMDA drugs
KMDA drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Mar 31 $8.34entry
- T+1 · 8mo ago +1.56%α +0.81% · $8.47
- T+5 · 7mo ago +1.56%α −2.39% · $8.47
- T+20 · 7mo ago −2.34%α −11.76% · $8.15
- T+60 · 5mo ago −12.95%α −25.33% · $7.26
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Kamada Ltd. announced a tax ruling from the Israel Tax Authority that allows eligible Nasdaq-listed shareholders to benefit from reduced Israeli withholding tax rates on its previously announced $0.25 per share cash dividend. The dividend, totaling approximately $14.4 million, is expected to be paid on April 7, 2026, to shareholders of record as of March 23, 2026.
Key Facts
- Company obtained a tax ruling from the Israel Tax Authority regarding dividend withholding procedures.
- Cash dividend of $0.25 per share ($14.4 million total) was previously announced on March 11, 2026.
- Dividend payment date is April 7, 2026, with record date of March 23, 2026.
- Nasdaq shareholders who are residents of countries with tax treaties with Israel may qualify for reduced withholding tax rates.
- Shareholders must submit required documentation to the tax agent by May 9, 2026 to benefit from reduced rates.
Financial Impact
$14.4 million total dividend payout; potential tax savings for eligible international shareholders
Risk Factors
- Shareholders who fail to meet documentation deadlines by May 9, 2026 will not receive tax refunds.
- The ruling only affects withholding procedures, not ultimate tax liability, which depends on individual circumstances.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-036822 |
| Document: ea0283955-6k_kamada.htm | 0001213900-26-036822 |
| Document: 0001213900-26-036822-index-headers.html | 0001213900-26-036822 |
| Document: 0001213900-26-036822-index.html | 0001213900-26-036822 |
| Document: 0001213900-26-036822.txt | 0001213900-26-036822 |
Track record
25 reports on KMDA
8 of 11 bullish or bearish reports moved the stock their way by T+5. Best: +16.13% at T+20 after the Aug 12, 2026 report. 10 of 11 went positive at some point.
Filters
- Nov 9, 20267d ago 6-K Bullish 6/10 No price data
- Nov 9, 20267d ago Press Release Bullish 6/10 Entry $7.71 to $8.11 Now $8.11 +5.19% ▲ +5.19% +6.88% vs SPY
- Nov 2, 202614d ago 6-K Neutral 2/10 Entry $7.36 to $7.71 Now $8.11 +10.19% ▲ +4.76% +4.68% vs SPY
- Oct 6, 20265w ago 6-K Neutral 4/10 Entry $8.11 to $7.69 Now $8.11 −0.00% ▼ −5.18% −5.04% vs SPY
- Oct 6, 20265w ago Press Release Bullish 6/10 Entry $8.11 to $7.69 Now $8.11 −0.00% ▼ −5.18% −5.04% vs SPY
- Oct 5, 20266w ago 6-K Neutral 2/10 Entry $8.11 to $7.69 Now $8.11 −0.00% ▼ −5.18% −5.04% vs SPY
- Sep 17, 20268w ago 6-K Bullish 6/10 Entry $8.67 to $8.83 Now $8.11 −6.46% ▲ +1.85% +1.24% vs SPY
- Sep 16, 20268w ago EFFECT Neutral 3/10 Entry $8.19 to $8.77 Now $8.11 −0.98% ▲ +7.08% +4.52% vs SPY
- Sep 10, 20269w ago 6-K Neutral 2/10 Entry $7.99 to $8.67 Now $8.11 +1.50% ▲ +8.51% +9.01% vs SPY
- Sep 3, 202610w ago Press Release Neutral 2/10 Entry $8.54 to $8.31 Now $8.11 −5.04% ▼ −2.69% −1.48% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers